Physician profile
Amanda Crowell
NPI 1730529389
$4,888.47
in general payments reported to CMS, 2019-2025
24 companies · $1,091 in 2025
The $1,091 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,342 · 2020: $83.10 · 2021: $638 · 2022: $1,003 · 2023: $500 · 2024: $233 · 2025: $1,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,301 · Travel and Lodging: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.58 |
| Travel and Lodging | $522.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,081.89 | 2019 | |
| Treace Medical Concepts, INC. | $1,017.83 | 2022-2025 | |
| Stryker Corporation | $819.81 | 2019-2024 | Allograft, Anchorage, Hoffmann |
| Organogenesis INC. | $649.52 | 2019-2025 | Puraply, Via Matrix |
| Smith+Nephew, INC. | $192.05 | 2021-2025 | Collagenase Santyl, Regranex, Grafix Pl |
| Zimmer Biomet Holdings, INC. | $173.68 | 2019-2021 | |
| Integra Lifesciences Corporation | $168.23 | 2022 | |
| Nevro Corp. | $109.49 | 2022 | |
| Kerecis Limited | $108.94 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Tactile Systems Technology INC | $100.43 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Medtronic, INC. | $98.22 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Averitas Pharma INC. | $88.51 | 2023-2024 | Qutenza |
| Paratek Pharmaceuticals, INC. | $53.67 | 2024-2025 | Nuzyra |
| Zimvie INC. | $32.12 | 2022-2023 | |
| Reapplix INC. | $29.33 | 2023 | 3c Patch Kit - Box |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $25.45 | 2021 | |
| Ani Pharmaceuticals, INC. | $22.29 | 2025 | Purified Cortrophin Gel |
| Abbvie INC. | $19.35 | 2023 | Teflaro, Dalvance |
| Convatec INC. | $17.97 | 2023 | |
| Bioventus LLC | $17.65 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $16.73 | 2025 | Journavx |
| Solventum Corporation | $16.42 | 2025 | Activ.A.C. |
| Kci USA, INC. | $15.82 | 2023 | Promogran Prisma, Activ.A.C., V.A.C. Dermatac |
| Kowa Pharmaceuticals America, INC. | $13.07 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Crowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.